Intravacc announces formation of Scientific Advisory Board
News provided by
Share this article
BILTHOVEN, the Netherlands, Feb. 23, 2021 /PRNewswire/
Intravacc, a world leader in translational research and development of vaccines, today announced the formation of a Scientific Advisory Board ( SAB ), chaired by Intravacc s Chief Scientific Officer Virgil Schijns and further comprising scientific leaders in the fields of vaccinology, infectious diseases and oncology. Intravacc s SAB will be consulted to help define the proper vaccine strategies and solutions to establish an impact on public health supported by convincing scientific clinical data. The SAB will also advise on the company s research strategy and approaches to optimize therapy effectiveness and added value.